SynthesisBMC cancer2025

First-line PD-1/PD-L1 inhibitors plus chemotherapy vs. chemotherapy alone in stage IIIB-IV non-squamous NSCLC: an updated meta-analysis of phase 3 RCTs.

Yunwei Rao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.